SurgiQuest, Inc. (“SurgiQuest” or the “Company”), a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced the appointment of Jaime Landman, M.D. as Chief Medical Director of the Company.
Dr. Landman is currently a Professor of Urology and Radiology and the Chairman of the Department of Urology at the University of California, Irvine School of Medicine, and is a well-respected member of the minimally invasive surgical community. During his professional career, he has authored or contributed to more than 200 peer-reviewed clinical publications, written more than 50 reviews, chapters, and editorials, and received numerous patents from the United States Patent and Trademark Office for surgical devices.
“I am both honored and excited to work with SurgiQuest,” said Dr. Landman. “My patients have enjoyed the remarkable benefits of the company’s AirSeal® iFS System, and I look forward to working with the SurgiQuest team to expand the use of this unique platform, and to help develop and deliver additional, market changing technology to the surgical community.”
Kurt Azarbarzin, SurgiQuest’s Founder and Chief Executive Officer, said, “We are absolutely thrilled to have someone of Dr. Landman’s prominence join our team at this exciting time in the company’s history. His clinical, technical, and strategic contributions in this pivotal role will ensure the continued growth and success of our company.”